Abstract
In our efforts to develop new drugs for the treatment of tuberculosis, especially that caused by multidrug-resistant strains, we investigated clofazimine (CFM) and two of its analogs, B4154 and B4157, for their antituberculosis activities. Twenty M. tuberculosis strains were tested, including 16 drug-resistant strains (strains resistant to one or more antituberculosis drugs), for their susceptibilities to these three agents. All of the strains were found to be susceptible to B4154 and B4157, and one strain showed moderate resistance to CFM. The MICs of B4154, B4157, and CFM at which 90% of strains were inhibited were 0.25, 0.12, and < or = 1.0 microgram/ml, respectively. The intracellular activities of CFM and B4157 were superior to that of B4154. The chemotherapeutic activities of the three compounds were evaluated in C57BL/6 mice. At a dose of 20 mg/kg of body weight, the activity of CFM was slightly superior to that of B4157; however, both compounds prevented mortality and caused a significant reduction in the numbers of CFU in the lungs and spleens. The animals treated with B4157 showed less pigmentation than animals treated with CFM. The chemotherapeutic activity of CFM was comparable to those of rifampin and isoniazid. Complete susceptibility of multidrug-resistant strains to CFM and B4157 and the therapeutic efficacies of these compounds against mouse tuberculosis make these drugs attractive agents for the treatment of drug-resistant tuberculosis.
Full Text
The Full Text of this article is available as a PDF (206.2 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- BARRY V. C., BELTON J. G., CONALTY M. L., DENNENY J. M., EDWARD D. W., O'SULLIVAN J. F., TWOMEY D., WINDER F. A new series of phenazines (rimino-compounds) with high antituberculosis activity. Nature. 1957 May 18;179(4568):1013–1015. doi: 10.1038/1791013a0. [DOI] [PubMed] [Google Scholar]
- BARRY V. C., CONALTY M. L. THE ANTIMYCOBACTERIAL ACTIVITY OF B 663. Lepr Rev. 1965 Jan;36:3–7. doi: 10.5935/0305-7518.19650002. [DOI] [PubMed] [Google Scholar]
- Gangadharam P. R., Ashtekar D., O'Sullivan J. F. In vitro, in vivo, and intracellular chemotherapeutic activity of B746, a clofazimine analogue against Mycobacterium avium complex. Tuber Lung Dis. 1992 Aug;73(4):192–199. doi: 10.1016/0962-8479(92)90085-x. [DOI] [PubMed] [Google Scholar]
- Gangadharam P. R., Perumal V. K., Podapati N. R., Kesavalu L., Iseman M. D. In vivo activity of amikacin alone or in combination with clofazimine or rifabutin or both against acute experimental Mycobacterium avium complex infections in beige mice. Antimicrob Agents Chemother. 1988 Sep;32(9):1400–1403. doi: 10.1128/aac.32.9.1400. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jagannath C., Reddy M. V., Kailasam S., O'Sullivan J. F., Gangadharam P. R. Chemotherapeutic activity of clofazimine and its analogues against Mycobacterium tuberculosis. In vitro, intracellular, and in vivo studies. Am J Respir Crit Care Med. 1995 Apr;151(4):1083–1086. doi: 10.1164/ajrccm/151.4.1083. [DOI] [PubMed] [Google Scholar]
- Lee C. N., Heifets L. B. Determination of minimal inhibitory concentrations of antituberculosis drugs by radiometric and conventional methods. Am Rev Respir Dis. 1987 Aug;136(2):349–352. doi: 10.1164/ajrccm/136.2.349. [DOI] [PubMed] [Google Scholar]
- Lindholm-Levy P. J., Heifets L. B. Clofazimine and other rimino-compounds: minimal inhibitory and minimal bactericidal concentrations at different pHs for Mycobacterium avium complex. Tubercle. 1988 Sep;69(3):179–186. doi: 10.1016/0041-3879(88)90019-0. [DOI] [PubMed] [Google Scholar]
- Reddy M. V., Srinivasan S., Andersen B., Gangadharam P. R. Rapid assessment of mycobacterial growth inside macrophages and mice, using the radiometric (BACTEC) method. Tuber Lung Dis. 1994 Apr;75(2):127–131. doi: 10.1016/0962-8479(94)90041-8. [DOI] [PubMed] [Google Scholar]
- Saito H., Sato K. Activity of rifabutin alone and in combination with clofazimine, kanamycin and ethambutol against Mycobacterium intracellulare infections in mice. Tubercle. 1989 Sep;70(3):201–205. doi: 10.1016/0041-3879(89)90051-2. [DOI] [PubMed] [Google Scholar]